Navigation Links
Isis Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference
Date:1/8/2009

CARLSBAD, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced that the Company will present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Stanley T. Crooke, M.D., Ph.D., Chairman and CEO of Isis, will provide an overview of the Company and an update on recent clinical and business activities.

The presentation will begin at 11:30 a.m. PT (2:30 p.m. ET) on Monday, January 12, 2009. To access the live audio webcast, log on to www.isispharm.com. In addition to the live webcast, the presentation will be archived for a limited time on the Company's Web site.

About Isis Pharmaceuticals, Inc.

Isis is exploiting its expertise in RNA to discover and develop novel drugs for its product pipeline and for its partners. The Company has successfully commercialized the world's first antisense drug and has 19 drugs in development. Isis' drug development programs are focused on treating cardiovascular and metabolic diseases. Isis' partners are developing antisense drugs invented by Isis to treat a wide variety of diseases. Isis is a joint owner of Regulus Therapeutics Inc., a joint venture focused on the discovery, development and commercialization of microRNA therapeutics. Isis also has made significant innovations beyond human therapeutics resulting in products that other companies, including Abbott, are commercializing. As an innovator in RNA-based drug discovery and development, Isis is the owner or exclusive licensee of over 1,600 issued patents worldwide. Additional information about Isis is available at www.isispharm.com.

This press release includes forward-looking statements regarding Isis Pharmaceuticals' business, the finan
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... of Montreal, the regions of the brain below the ... bodies, movements and, critically, they interact more effectively after ... helped us the learn sequences of movements (motor learning), ... important in information consolidation, especially information linked to a ... a period of sleep, the brain network of these ...
(Date:8/21/2014)... Artisan Business Group Inc., will lead the 3rd ... China October 12-19, 2014. The 2014 EB-5 Delegation provides ... of Shenzhen and Guangzhou. This trip is specifically organized ... meet with major Chinese migration agents and businesses to ... , The trade mission activities include: meetings with ...
(Date:8/21/2014)... Quantum Innovations, Inc . and ... announce the healthcare technology platform, PWeR® 2.0 , ... The company anticipates provisioning its first provider over the ... physicians, via interfaces, to medical laboratory, pharmacy, secure fax ... data exchanges and medical clearing houses. , Noel ...
(Date:8/21/2014)... Being overweight or obese may be one ... is no cure, patients have learned how to ... such as losing excess weight and following a medically ... joint disorder which causes discomfort and pain in the ... significantly reduce one’s quality of life. Although it is ...
(Date:8/21/2014)... 2014 Poorly-made dental restorations – whether ... a range of health consequences for patients. To ensure ... important that dentists and patients have a full understanding ... what materials are used in the process. , Some ... office. Others do not even think twice about where ...
Breaking Medicine News(10 mins):Health News:Learning to play the piano? Sleep on it! 2Health News:Artisan Business Group announces 2014 EB-5 Investment Trade Mission to China 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 2Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 3Health News:Grace Century’s Electronic Health Records Project, Quantum Innovations, Announces That PWeR® Healthcare Technology Platform is Ready for Deployment 4Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 2Health News:Diet Doc’s Medical Weight Loss Programs Announces Safe and Fast Weight Loss That Teach Patients How to Relieve Osteoarthritis Pain 3Health News:4 Questions to Ask Before Your Next Dentist Appointment 2Health News:4 Questions to Ask Before Your Next Dentist Appointment 3
... Starpharma Holdings Limited announced the commencement in the U.S. ... of SPL7013 Gel (VivaGel(TM)) in sexually active young ... the study, funded by the U.S. National Institutes of ... the first time in sexually active young women to ...
... in the United States -- more than double the percentage ... at least 21 serious disorders, according to the latest ... has failed to make progress on expanding the newborn screening ... of Columbia require screening for the 29 core, treatable, conditions. ...
... smart enough to cash in on the Dutch laws. ... on a marijuana cookie while touring in the Netherlands. ... it is not legal here. I don't ever do anything ... ,The 25-year-old singer said that the cookie was ...
... be participating in the Memory Ride for Alzheimer's Research on ... the disease that affects more than 5 million Americans. ... Memory Ride has a personal story to tell -- about ... struggled with the disease. ,The Alzheimer's Association is ...
... spotted returning home without her shoes at 5 in the morning ... jailbird had been to a party at the Sunset Tower Hotel ... the hotel heiress rep said that Hilton was exhausted after visiting ... ,The Simple Life star returned to the LA club scene ...
... million worldwide. In a new study, UCLA researchers measured the ... beyond just the physical symptoms of the disease and ... well-being, which may help clinicians guide treatment. The study appears ... ,Our results revealed that to effectively treat hepatitis B patients, ...
Cached Medicine News:Health News:Trial of VivaGel in Sexually Active Young Women Commences 2Health News:All Babies in Massachusetts Should Be Screened for Life-Threatening Disorders 2Health News:Researchers Develop Tool to Gauge Quality of Life of Hepatitis B Patients 2
(Date:8/21/2014)... Aug. 21, 2014  Armada Health Care (Armada), ... (GPO), is pleased to announce an agreement with ... host of innovative specialty pharmacy patient program offerings. ... therapy management services to specialty patients via Armada,s ... Aurora will use the OTM platform as ...
(Date:8/21/2014)... 2014 Professional Compounding Centers of America ... awarding the three best scientific presentations at the ... . The Formulating Better Medicines for Children ... Athens, Greece , includes dozens of ... from which three winners will be selected by ...
(Date:8/21/2014)...  SI-BONE, Inc. ( San Jose, California ... of the iFuse Implant System, ® a minimally ... sacroiliac (SI) joint, announced that Priority Health ( ... Fusion Medical Policy No. 91590-R4 providing positive coverage for ... that the fusion procedure, which employs the iFuse Implant ...
Breaking Medicine Technology:Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3Professional Compounding Centers of America will award top poster-session winners at European Paediatric Formulation Initiative in Athens 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 2SI-BONE, Inc. Announces Positive Coverage Decision by Priority Health 3
... Calif. , Feb. 18 AutoGenomics, a ... that the organization has been awarded the ISO 13485 ... throughout the organization. TUV SUD America Inc. was the ... looks to expand its increasing role in the international ...
... CAUSE NO. 2010-10259, , BRAD KOVNAT, ... , ... , v. ... , THE PALLADIUM FOR SURGERY- ...
Cached Medicine Technology:AutoGenomics Receives ISO Certification 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 2Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 3Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 4Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 5Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 6Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 7Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 8Texas Court Asked to Appoint Receiver for Key Subsidiary of TSX Listed Northstar Healthcare, Inc. (TSX NHC) on Claims of Mismanagement and Breach of Fiduciary Duty 9
... ,MARS Technology is the next generation in ... addition to our current family of "digital ... of new technological breakthroughs in signal processing. ... signal resulting in superior performance during challenging ...
The new Nellcor N-45 Handheld Pulse Oximeter is compatible with our complete line of OxiMax Pulse Oximetry Sensors, so clinicians have the convenience of Nellcors most advanced sensor technology in a...
... handheld oximeter has been converted to the ... now compatible with the entire line of ... Sensor and SoftCare Nonadhesive Sensors. The redesigned ... Nellcor's latest advanced signal processing technology, which ...
... The Nellcor N395 Pulse Oximeter with ... challenging motion conditions, cutting through nonspecific noise ... SpO 2 and pulse rate values. ... equipped with SatSeconds Alarm Management, a breakthrough ...
Medicine Products: